A proof-of-concept trial in psoriasis patients

Trial Profile

A proof-of-concept trial in psoriasis patients

Planning
Phase of Trial: Phase I

Latest Information Update: 23 May 2018

At a glance

  • Drugs Ciclosporin (Primary)
  • Indications Psoriasis
  • Focus Adverse reactions; Proof of concept
  • Most Recent Events

    • 23 May 2018 According to Immune Pharmaceuticals media release, trial is expected to start in the fourth quarter of 2018 or early in the first quarter of 2019.
    • 22 Feb 2018 New trial record
    • 20 Feb 2018 According to Immune Pharmaceuticals media release, trial is expected to start in 2H 2018
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top